Emergent BioSolutions Reports First Quarter 2014 Financial Results

[Business Wire] – Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.2 more

View todays social media effects on EBS

View the latest stocks trending across Twitter. Click to view dashboard

See who Emergent is hiring next, click here to view